These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 27523462)

  • 1. Prognostic Impact of BNP Variations in Patients Admitted for Acute Decompensated Heart Failure with In-Hospital Worsening Renal Function.
    Stolfo D; Stenner E; Merlo M; Porto AG; Moras C; Barbati G; Aleksova A; Buiatti A; Sinagra G
    Heart Lung Circ; 2017 Mar; 26(3):226-234. PubMed ID: 27523462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Worsening of renal function during 1 year after hospital discharge is a strong and independent predictor of all-cause mortality in acute decompensated heart failure.
    Ueda T; Kawakami R; Sugawara Y; Okada S; Nishida T; Onoue K; Soeda T; Okayama S; Takeda Y; Watanabe M; Kawata H; Uemura S; Saito Y
    J Am Heart Assoc; 2014 Nov; 3(6):e001174. PubMed ID: 25370599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The paradox of transient worsening renal function in patients with acute heart failure: the role of B-type natriuretic peptide and diuretic response.
    Ruocco G; Nuti R; Giambelluca A; Evangelista I; De Vivo O; Daniello C; Palazzuoli A
    J Cardiovasc Med (Hagerstown); 2017 Nov; 18(11):851-858. PubMed ID: 28704280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison between admission natriuretic peptides, NGAL and sST2 testing for the prediction of worsening renal function in patients with acutely decompensated heart failure.
    De Berardinis B; Gaggin HK; Magrini L; Belcher A; Zancla B; Femia A; Simon M; Motiwala S; Bhardwaj A; Parry BA; Nagurney JT; Coudriou C; Legrand M; Sadoune M; Di Somma S; Januzzi JL;
    Clin Chem Lab Med; 2015 Mar; 53(4):613-21. PubMed ID: 25473804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Competing Risk of Cardiac Status and Renal Function During Hospitalization for Acute Decompensated Heart Failure.
    Salah K; Kok WE; Eurlings LW; Bettencourt P; Pimenta JM; Metra M; Verdiani V; Tijssen JG; Pinto YM
    JACC Heart Fail; 2015 Oct; 3(10):751-61. PubMed ID: 26449995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. B-type natriuretic peptide trend predicts clinical significance of worsening renal function in acute heart failure.
    Wettersten N; Horiuchi Y; van Veldhuisen DJ; Mueller C; Filippatos G; Nowak R; Hogan C; Kontos MC; Cannon CM; Müeller GA; Birkhahn R; Taub P; Vilke GM; Barnett O; McDonald K; Mahon N; Nuñez J; Briguori C; Passino C; Murray PT; Maisel A
    Eur J Heart Fail; 2019 Dec; 21(12):1553-1560. PubMed ID: 31769140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Worsening renal function is not associated with response to treatment in acute heart failure.
    Ather S; Bavishi C; McCauley MD; Dhaliwal A; Deswal A; Johnson S; Chan W; Aguilar D; Pritchett AM; Ramasubbu K; Wehrens XH; Bozkurt B
    Int J Cardiol; 2013 Sep; 167(5):1912-7. PubMed ID: 22633437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The utilization and prognostic impact of B-type Natriuretic Peptide in hospitalized acute decompensated heart failure in an Asian population.
    Chen LJ; Hung CL; Yeh HI; Jeng MJ; Su CH; Wu TY; Shih SC; Tsai CH
    BMC Cardiovasc Disord; 2016 Sep; 16(1):178. PubMed ID: 27613439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Change in the NT-proBNP/Mature BNP Molar Ratio Precedes Worsening Renal Function in Patients With Acute Heart Failure: A Novel Predictor Candidate for Cardiorenal Syndrome.
    Takahama H; Nishikimi T; Takashio S; Hayashi T; Nagai-Okatani C; Asada T; Fujiwara A; Nakagawa Y; Amano M; Hamatani Y; Okada A; Amaki M; Hasegawa T; Kanzaki H; Nishimura K; Yasuda S; Kangawa K; Anzai T; Minamino N; Izumi C
    J Am Heart Assoc; 2019 Sep; 8(17):e011468. PubMed ID: 31441355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimizing fluid management in patients with acute decompensated heart failure (ADHF): the emerging role of combined measurement of body hydration status and brain natriuretic peptide (BNP) levels.
    Valle R; Aspromonte N; Milani L; Peacock FW; Maisel AS; Santini M; Ronco C
    Heart Fail Rev; 2011 Nov; 16(6):519-29. PubMed ID: 21604179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of brain natriuretic peptide reduction on the worsening renal function in patients with acute heart failure.
    Yoshioka K; Matsue Y; Okumura T; Kida K; Oishi S; Akiyama E; Suzuki S; Yamamoto M; Mizukami A; Kuroda S; Kagiyama N; Yamaguchi T; Sasano T; Matsumura A; Kitai T
    PLoS One; 2020; 15(6):e0235493. PubMed ID: 32589688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Admission plasma neutrophil gelatinase associated lipocalin (NGAL) predicts worsening renal function during hospitalization and post discharge outcome in patients with acute heart failure.
    Palazzuoli A; Ruocco G; Beltrami M; Franci B; Pellegrini M; Lucani B; Nuti R; Ronco C
    Acute Card Care; 2014 Sep; 16(3):93-101. PubMed ID: 24836558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tolvaptan reduces the risk of worsening renal function in patients with acute decompensated heart failure in high-risk population.
    Matsue Y; Suzuki M; Seya M; Iwatsuka R; Mizukami A; Nagahori W; Ohno M; Matsumura A; Hashimoto Y
    J Cardiol; 2013 Feb; 61(2):169-74. PubMed ID: 23159210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NT-pro-BNP predicts worsening renal function in patients with chronic systolic heart failure.
    Pfister R; Müller-Ehmsen J; Hagemeister J; Hellmich M; Erdmann E; Schneider CA
    Intern Med J; 2011 Jun; 41(6):467-72. PubMed ID: 20214692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Worsening Renal Function during Management for Chronic Heart Failure with Reduced Ejection Fraction: Results From the Pro-BNP Outpatient Tailored Chronic Heart Failure Therapy (PROTECT) Study.
    Ibrahim NE; Gaggin HK; Rabideau DJ; Gandhi PU; Mallick A; Januzzi JL
    J Card Fail; 2017 Feb; 23(2):121-130. PubMed ID: 27469482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain natriuretic peptide at discharge as a predictor of 6-month mortality in acute decompensated heart failure.
    Naffaa M; Makhoul BF; Tobia A; Jarous M; Kaplan M; Aronson D; Saliba W; Azzam ZS
    Am J Emerg Med; 2014 Jan; 32(1):44-9. PubMed ID: 24210886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Poor concordance between different definitions of worsening renal function in patients with acute exacerbation of chronic heart failure: a retrospective study.
    De Vecchis R; Baldi C; Di Biase G
    Minerva Cardioangiol; 2016 Apr; 64(2):127-37. PubMed ID: 25423291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of serial increases in amino-terminal pro-B-type natriuretic peptide levels to indicate the need for mechanical circulatory support in children with acute decompensated heart failure.
    Wong DT; George K; Wilson J; Manlhiot C; McCrindle BW; Adeli K; Kantor PF
    Am J Cardiol; 2011 Feb; 107(4):573-8. PubMed ID: 21295174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between worsening renal function and long-term cardiovascular mortality in heart failure patients.
    Okabe T; Yakushiji T; Kido T; Oyama Y; Igawa W; Ono M; Ebara S; Yamashita K; Yamamoto MH; Saito S; Amemiya K; Isomura N; Araki H; Ochiai M
    Int J Cardiol; 2017 Mar; 230():47-52. PubMed ID: 28038802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative evaluation of B-type natriuretic peptide and mid-regional pro-A-type natriuretic peptide changes from admission to discharge in prognosis of acute decompensated heart failure patients.
    Stenner E; Buiatti A; Barbati G; Merlo M; Sinagra G; Biasioli B
    Clin Lab; 2012; 58(5-6):585-9. PubMed ID: 22783593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.